Docetaxel With or Without PI-88 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Lung Cancer
Interventions
DRUG

PI-88

PI-88+docetaxel

DRUG

docetaxel

docetaxel only

Trial Locations (13)

2031

Institute of Oncology at Prince of Wales Hospital, Randwick

2050

Sydney Cancer Centre at Royal Prince Alfred Hospital, Sydney

2065

Royal North Shore Hospital, St Leonards

2077

Sydney Heamatology and Oncology Clinics, Hornsby

2298

Newcastle Mater Misericordiae Hospital, Waratah

3004

Alfred Hospital, Melbourne

3690

Murray Valley Private Hospital and Cancer Treatment Centre, Wodonga

4032

Prince Charles Hospital, Chermside

4101

Mater Medical Centre, South Brisbane

4102

Princess Alexandra Hospital, Brisbane

4560

Nambour General Hospital, Nambour

5011

Queen Elizabeth Hospital, Woodville

6009

Sir Charles Gairdner Hospital - Perth, Perth

All Listed Sponsors
collaborator

Medigen Biotechnology Corporation

INDUSTRY

lead

Cellxpert Biotechnology Corp.

INDUSTRY